“Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis”, Reumatismo, vol. 62, no. 4, pp. 253–258, Dec. 2010, doi: 10.4081/reumatismo.2010.253.